T
Torp-Pedersen Ct
Researcher at Odense University Hospital
Publications - 51
Citations - 4686
Torp-Pedersen Ct is an academic researcher from Odense University Hospital. The author has contributed to research in topics: Myocardial infarction & Heart failure. The author has an hindex of 22, co-authored 51 publications receiving 4492 citations.
Papers
More filters
Journal ArticleDOI
A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.
Lars Køber,Torp-Pedersen Ct,Carlsen Je,Henning Bagger,Eliasen P,Lyngborg K,Jørgen Videbæk,D. S. Cole,L. Auclert,N. C. Pauly +9 more
TL;DR: Long-term treatment with trandolapril in patients with reduced left ventricular function soon after myocardial infarction significantly reduced the risk of overall mortality, mortality from cardiovascular causes, sudden death, and the development of severe heart failure.
Journal ArticleDOI
Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.
Torp-Pedersen Ct,Mogens Møller,P E Bloch-Thomsen,Lars Køber,Erik Sandoe,Kenneth Egstrup,Agner E,Carlsen Je,Jørgen Videbæk,Bradley Marchant,A. J. Camm +10 more
TL;DR: In patients with congestive heart failure and reduced left ventricular function, dofetilide was effective in converting atrial fibrillation, preventing its recurrence, and reducing the risk of hospitalization for worsening heart failure.
Journal ArticleDOI
The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens
Hanne Elming,Ellen Holm,L. Jun,Torp-Pedersen Ct,Lars Køber,M. Kircshoff,Marek Malik,John Camm +7 more
TL;DR: Prolongation of the QT intervals and QT interval dispersion independently affected the prognosis of cardiovascular mortality and cardiac fatal and non-fatal morbidity in a general population over 11 years.
Journal ArticleDOI
Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects.
TL;DR: The relevant range of doses of bendrofluazide to treat mild to moderate hypertension is 1.25-2.5 mg a day, and clear relations between dose and effect were shown for potassium, urate, glucose, total cholesterol, and apolipoprotein B concentrations.
Journal ArticleDOI
The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction
TL;DR: Atrial fibrillation/-flutter often occurs after acute myocardial infarction and its analysis demonstrated that it was an independent predictor of an increased short and long-term mortality.